Guillain Barré syndrome
Clinical trials for Guillain Barré syndrome explained in plain language.
Never miss a new study
Get alerted when new Guillain Barré syndrome trials appear
Sign up with your email to follow new studies for Guillain Barré syndrome, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new drug shorten Guillain-Barré recovery?
Disease control Not yet recruitingThis trial tests whether efgartigimod, a drug that lowers harmful antibody levels, can improve recovery in people with Guillain-Barré syndrome (GBS), a rare nerve condition that can cause weakness and paralysis. Adults aged 18 to 70 with recent GBS onset will receive either efgar…
Matched conditions: GUILLAIN BARRÉ SYNDROME
Phase 2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study seeks clues to help kids recover from Guillain-Barré
Knowledge-focused Not yet recruitingThis study will look at medical and lab factors that influence how children with Guillain-Barré syndrome recover. Researchers will follow 80 children to see which ones fully recover within 3 months. The goal is to create better ways to predict outcomes and guide treatment.
Matched conditions: GUILLAIN BARRÉ SYNDROME
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC